Interpretation of FEV1 Values in Pulmonary Function Assessment

Introduction to FEV1 Measurement

The European Respiratory Society guidelines indicate that an FEV1 of 72% predicted represents mild airflow limitation, which falls within the mild category of pulmonary function impairment 1, 2
FEV1 is a key spirometric measurement that represents the volume of air exhaled in the first second of a forced expiratory maneuver, according to the European Respiratory Society 1
The percentage value of FEV1 (such as 72%) compares the actual measurement to the predicted value for someone of the same age, height, sex, and ethnicity, as stated by the European Respiratory Society 3

The European Respiratory Society guidelines classify an FEV1 of 72% as mild impairment, which is defined as an FEV1 between 70-79% of the predicted value 1, 2
This level of lung function may be associated with minimal or no symptoms in many individuals, according to the Thorax journal 4
In COPD classification, an FEV1 of 72% would be considered mild COPD when accompanied by airflow obstruction, as indicated by the European Respiratory Society and Thorax journal 2, 4
An FEV1 of 72% alone does not establish a diagnosis without considering other parameters, such as the FEV1/FVC ratio, according to the European Respiratory Society 1
The FEV1/FVC ratio must also be evaluated to determine if there is true obstruction, as stated by the European Respiratory Society 5
FEV1 may not always correlate well with symptoms and may not accurately predict clinical severity or prognosis for individual patients, according to the European Respiratory Society 1

Using only FEV1 without considering the FEV1/FVC ratio can lead to misdiagnosis, as warned by the European Respiratory Society 5
Evaluating the FEV1/FVC ratio is necessary to determine if obstruction is present, according to the European Respiratory Society 1, 5
Bronchodilator testing should be considered to assess for reversibility of any airflow limitation, as recommended by the European Respiratory Society 1
Assessing for symptoms such as cough, sputum production, or breathlessness may correlate with this mild reduction in FEV1, according to the Thorax journal 4
If obstruction is confirmed, further evaluation for specific conditions like asthma or COPD may be warranted, as indicated by the Thorax journal 4
Additional testing such as lung volumes or diffusing capacity may be considered if clinically indicated, according to the European Respiratory Society 1